Skip to main content
Top
Published in: Breast Cancer Research 6/2010

Open Access 01-12-2010 | Research article

Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway

Authors: Lulu Mao, Lin Yuan, Lauren M Slakey, Frank E Jones, Matthew E Burow, Steven M Hill

Published in: Breast Cancer Research | Issue 6/2010

Login to get access

Abstract

Introduction

The pineal gland hormone, melatonin, has been shown by numerous studies to inhibit the proliferation of estrogen receptor α (ERα)-positive breast cancer cell lines. Here, we investigated the role of melatonin in the regulation of breast cancer cell invasion.

Methods

Three invasive MCF-7 breast cancer cell clones - MCF-7/6, MCF-7/Her2.1, and MCF-7/CXCR4 cells - were employed in these studies. All three cell lines exhibited elevated phosphorylation of the ERK1/2 and p38 mitogen-activated protein kinase (MAPK) as determined by Western blot analysis. The effect of melatonin on the invasive potential of these human breast cancer cells was examined by matrigel invasion chamber assays. The expression and proteinase activity of two matrix metalloproteinases (MMPs), MMP-2 and MMP-9, were analyzed by Western blot analysis and gelatin zymography, respectively.

Results

Melatonin (10-9 M) significantly suppressed the invasive potential of MCF-7/6 and MCF-7/Her2.1 cells as measured by matrigel invasion chamber assays, and significantly repressed the proteinase activity of MMP-2 and MMP-9. In MCF-7/CXCR4 cells, melatonin significantly inhibited stromal-derived factor-1 (SDF-1/CXCL12) induced cell invasion and activity of MMP-9. Elevated expression of the MT1 melatonin receptor further enhanced, while luzindole, an MT1/MT2 antagonist, abrogated melatonin's anti-invasive effect, suggesting that melatonin's effect on invasion is mediated, principally, through the MT1 receptor. Furthermore, melatonin repressed the phosphorylation of p38 MAPK in MCF-7/Her2.1 cells and blocked stromal-derived factor-1 (SDF-1) induced p38 phosphorylation in MCF-7/CXCR4 cells. SB230580, a p38 inhibitor, was able to mimic, while transfection of the cells with a constitutively-active MKK6b construct blocked melatonin's effect on cell invasion, suggesting that the anti-invasive action of melatonin is mediated through the p38 pathway.

Conclusions

Melatonin exerts an inhibitory effect on breast cancer cell invasion through down-regulation of the p38 pathway, and inhibition of MMP-2 and MMP-9 expression and activity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Barni S, Lissoni P, Crispino S, Cattaneo G, Rovelli F, Fumagalli G, Tancini G: Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratio. Int J Biol Markers. 1988, 3: 82-86.PubMed Barni S, Lissoni P, Crispino S, Cattaneo G, Rovelli F, Fumagalli G, Tancini G: Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratio. Int J Biol Markers. 1988, 3: 82-86.PubMed
2.
go back to reference Lissoni P, Bastone A, Sala R, Mauri R, Rovelli F, Viviani S, Bajetta E, Esposti D, Esposti G, di Bella L, Fraschini F: The clinical significance of melatonin serum determination in oncological patients and its correlation with GH and PRL blood levels. Eur J Cancer Clin Oncol. 1987, 23: 949-957. 10.1016/0277-5379(87)90340-3.CrossRefPubMed Lissoni P, Bastone A, Sala R, Mauri R, Rovelli F, Viviani S, Bajetta E, Esposti D, Esposti G, di Bella L, Fraschini F: The clinical significance of melatonin serum determination in oncological patients and its correlation with GH and PRL blood levels. Eur J Cancer Clin Oncol. 1987, 23: 949-957. 10.1016/0277-5379(87)90340-3.CrossRefPubMed
3.
go back to reference Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ: Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998, 58: 4383-4390.PubMed Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ: Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998, 58: 4383-4390.PubMed
4.
go back to reference Anisimov VN, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Manton KG, Semenchenko AV, Yashin AI: The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer. 2003, 103: 300-305. 10.1002/ijc.10827.CrossRefPubMed Anisimov VN, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Manton KG, Semenchenko AV, Yashin AI: The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer. 2003, 103: 300-305. 10.1002/ijc.10827.CrossRefPubMed
5.
go back to reference Baturin DA, Alimova IN, Anisimov VN, Popovich IG, Zabezhinski MA, Provinciali M, Mancini R, Franceschi C: The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuro Endocrinol Lett. 2001, 22: 441-447.PubMed Baturin DA, Alimova IN, Anisimov VN, Popovich IG, Zabezhinski MA, Provinciali M, Mancini R, Franceschi C: The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuro Endocrinol Lett. 2001, 22: 441-447.PubMed
6.
go back to reference Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo D: Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo an in vitro. J Pineal Res. 2003, 35: 204-211. 10.1034/j.1600-079X.2003.00077.x.CrossRefPubMed Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo D: Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo an in vitro. J Pineal Res. 2003, 35: 204-211. 10.1034/j.1600-079X.2003.00077.x.CrossRefPubMed
7.
go back to reference Bracke ME, Van Larebeke NA, Vyncke BM, Mareel MM: Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br J Cancer. 1991, 63: 867-872.CrossRefPubMedPubMedCentral Bracke ME, Van Larebeke NA, Vyncke BM, Mareel MM: Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br J Cancer. 1991, 63: 867-872.CrossRefPubMedPubMedCentral
8.
go back to reference Correc P, Fondaneche M-C, Bracke M, Burtin P: The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer. 1990, 46: 745-750. 10.1002/ijc.2910460432.CrossRefPubMed Correc P, Fondaneche M-C, Bracke M, Burtin P: The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer. 1990, 46: 745-750. 10.1002/ijc.2910460432.CrossRefPubMed
9.
go back to reference Holbro T, Civenni G, Hynes NE: The ErbB receptors and their role in cancer progression. Exp Cell Res. 2003, 284: 99-110. 10.1016/S0014-4827(02)00099-X.CrossRefPubMed Holbro T, Civenni G, Hynes NE: The ErbB receptors and their role in cancer progression. Exp Cell Res. 2003, 284: 99-110. 10.1016/S0014-4827(02)00099-X.CrossRefPubMed
10.
go back to reference Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 1988, 48: 1238-1243.PubMed Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 1988, 48: 1238-1243.PubMed
11.
go back to reference Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D: Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells. Mol Endocrinol. 2001, 15: 1344-1359. 10.1210/me.15.8.1344.PubMed Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D: Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells. Mol Endocrinol. 2001, 15: 1344-1359. 10.1210/me.15.8.1344.PubMed
12.
go back to reference Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP: ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer. 2000, 82: 666-674. 10.1054/bjoc.1999.0979.CrossRefPubMedPubMedCentral Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP: ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer. 2000, 82: 666-674. 10.1054/bjoc.1999.0979.CrossRefPubMedPubMedCentral
13.
go back to reference Tan M, Yao J, Yu D: Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res. 1997, 57: 1199-1205.PubMed Tan M, Yao J, Yu D: Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res. 1997, 57: 1199-1205.PubMed
14.
go back to reference Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA: Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2002, 2: 451-461. 10.1016/S1535-6108(02)00212-X.CrossRefPubMed Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA: Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2002, 2: 451-461. 10.1016/S1535-6108(02)00212-X.CrossRefPubMed
15.
go back to reference Ke Z, Lin H, Fan Z, Cai TQ, Kaplan RA, Ma C, Bower KA, Shi X, Luo J: MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2. Int J Cancer. 2006, 119: 8-16. 10.1002/ijc.21769.CrossRefPubMed Ke Z, Lin H, Fan Z, Cai TQ, Kaplan RA, Ma C, Bower KA, Shi X, Luo J: MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2. Int J Cancer. 2006, 119: 8-16. 10.1002/ijc.21769.CrossRefPubMed
16.
go back to reference Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410: 50-56.CrossRefPubMed Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410: 50-56.CrossRefPubMed
17.
go back to reference Liang ZX, Yoon YH, Votaw H, Goodman MM, Williams L, Shim H: Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 2005, 65: 967-971.PubMedPubMedCentral Liang ZX, Yoon YH, Votaw H, Goodman MM, Williams L, Shim H: Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 2005, 65: 967-971.PubMedPubMedCentral
18.
go back to reference Chen Y, Stamatoyannopoulos G, Song CZ: Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 2003, 63: 4801-4804.PubMed Chen Y, Stamatoyannopoulos G, Song CZ: Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 2003, 63: 4801-4804.PubMed
19.
go back to reference Bendall LJ, Baraz R, Juarez J, She W, Bradstock KF: Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia. Cancer Res. 2005, 65: 3290-3298.PubMed Bendall LJ, Baraz R, Juarez J, She W, Bradstock KF: Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia. Cancer Res. 2005, 65: 3290-3298.PubMed
20.
go back to reference Rousseau S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nebreda AR, Arthur JS, Case LM, Tessier-Lavigne M, Gaestel M, Cuenda A, Cohen P: CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal. 2006, 18: 1897-1905. 10.1016/j.cellsig.2006.02.006.CrossRefPubMed Rousseau S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nebreda AR, Arthur JS, Case LM, Tessier-Lavigne M, Gaestel M, Cuenda A, Cohen P: CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal. 2006, 18: 1897-1905. 10.1016/j.cellsig.2006.02.006.CrossRefPubMed
21.
go back to reference Robledo MM, Bartolome RA, Longo N, Rodríguez-Frade JM, Mellado M, Longo I, van Muijen GN, Sánchez-Mateos P, Teixidó J: Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem. 2001, 276: 45098-45105. 10.1074/jbc.M106912200.CrossRefPubMed Robledo MM, Bartolome RA, Longo N, Rodríguez-Frade JM, Mellado M, Longo I, van Muijen GN, Sánchez-Mateos P, Teixidó J: Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem. 2001, 276: 45098-45105. 10.1074/jbc.M106912200.CrossRefPubMed
22.
go back to reference Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S: Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cell. J Biol Chem. 2002, 277: 48379-48385. 10.1074/jbc.M209542200.CrossRefPubMed Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S: Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cell. J Biol Chem. 2002, 277: 48379-48385. 10.1074/jbc.M209542200.CrossRefPubMed
23.
go back to reference Kim MS, Lee EJ, Kim HR, Moon A: p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 2003, 63: 5454-5461.PubMed Kim MS, Lee EJ, Kim HR, Moon A: p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 2003, 63: 5454-5461.PubMed
24.
go back to reference Cardone RA, Bagorda A, Bellizzi A, Busco G, Guerra L, Paradiso A, Casavola V, Zaccolo M, Reshkin SJ: Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol Biol Cell. 2005, 16: 3117-3127. 10.1091/mbc.E04-10-0945.CrossRefPubMedPubMedCentral Cardone RA, Bagorda A, Bellizzi A, Busco G, Guerra L, Paradiso A, Casavola V, Zaccolo M, Reshkin SJ: Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol Biol Cell. 2005, 16: 3117-3127. 10.1091/mbc.E04-10-0945.CrossRefPubMedPubMedCentral
25.
go back to reference Shin I, Kim S, Song H, Kim HR, Moon A: H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem. 2005, 280: 14675-14683. 10.1074/jbc.M411625200.CrossRefPubMed Shin I, Kim S, Song H, Kim HR, Moon A: H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem. 2005, 280: 14675-14683. 10.1074/jbc.M411625200.CrossRefPubMed
26.
go back to reference Delghandi MP, Johannessen M, Moens U: The cAMP signaling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal. 2005, 17: 1343-1351. 10.1016/j.cellsig.2005.02.003.CrossRefPubMed Delghandi MP, Johannessen M, Moens U: The cAMP signaling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal. 2005, 17: 1343-1351. 10.1016/j.cellsig.2005.02.003.CrossRefPubMed
27.
go back to reference Suzuki A, Palmer G, Bonjour JP, Caverzasio J: Regulation of alkaline phoaphatase activity of p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology. 1999, 140: 3177-3182. 10.1210/en.140.7.3177.PubMed Suzuki A, Palmer G, Bonjour JP, Caverzasio J: Regulation of alkaline phoaphatase activity of p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology. 1999, 140: 3177-3182. 10.1210/en.140.7.3177.PubMed
28.
go back to reference Husain S, Abdel-Latif AA: Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholiase A2 in cat iris sphincter smooth muscle cells. Biochem J. 1999, 342: 87-96. 10.1042/0264-6021:3420087.PubMedPubMedCentral Husain S, Abdel-Latif AA: Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholiase A2 in cat iris sphincter smooth muscle cells. Biochem J. 1999, 342: 87-96. 10.1042/0264-6021:3420087.PubMedPubMedCentral
29.
go back to reference Komatsu J, Yamano S, Kuwahara A, Tokumura A, Irahara M: The signaling pathways linking to lysophosphatidic aid-promoted meiotic maturation in mice. Life Sci. 2006, 79: 506-511. 10.1016/j.lfs.2006.01.028.CrossRefPubMed Komatsu J, Yamano S, Kuwahara A, Tokumura A, Irahara M: The signaling pathways linking to lysophosphatidic aid-promoted meiotic maturation in mice. Life Sci. 2006, 79: 506-511. 10.1016/j.lfs.2006.01.028.CrossRefPubMed
30.
go back to reference Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka BK, Xiao RP: Beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or Gbeta gamma in a adult mouse cardiomyocytes. J Biol Chem. 2000, 275: 40635-40640. 10.1074/jbc.M006325200.CrossRefPubMed Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka BK, Xiao RP: Beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or Gbeta gamma in a adult mouse cardiomyocytes. J Biol Chem. 2000, 275: 40635-40640. 10.1074/jbc.M006325200.CrossRefPubMed
31.
go back to reference Kiefer TL, Yuan L, Ram PT, Hill SM: Melatonin inhibits estrogen receptor transactivation and cAMP levels in MCF-7 human breast cancer cells. Breast Cancer Res Treat. 2002, 71: 37-45. 10.1023/A:1013301408464.CrossRefPubMed Kiefer TL, Yuan L, Ram PT, Hill SM: Melatonin inhibits estrogen receptor transactivation and cAMP levels in MCF-7 human breast cancer cells. Breast Cancer Res Treat. 2002, 71: 37-45. 10.1023/A:1013301408464.CrossRefPubMed
32.
go back to reference Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L, Hill SM: Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett. 2002, 179: 141-150. 10.1016/S0304-3835(01)00873-4.CrossRefPubMed Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L, Hill SM: Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett. 2002, 179: 141-150. 10.1016/S0304-3835(01)00873-4.CrossRefPubMed
33.
go back to reference Fernandis AZ, Prasad A, Band H, Klosel R, Ganju RK: Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene. 2004, 23: 157-167. 10.1038/sj.onc.1206910.CrossRefPubMed Fernandis AZ, Prasad A, Band H, Klosel R, Ganju RK: Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene. 2004, 23: 157-167. 10.1038/sj.onc.1206910.CrossRefPubMed
34.
go back to reference Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM: MT1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol. 2002, 192: 147-156. 10.1016/S0303-7207(02)00029-1.CrossRefPubMed Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM: MT1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol. 2002, 192: 147-156. 10.1016/S0303-7207(02)00029-1.CrossRefPubMed
35.
go back to reference Collins A, Yuan L, Kiefer TL, Cheng Q, Lai L, Hill SM: Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett. 2003, 189: 49-57. 10.1016/S0304-3835(02)00502-5.CrossRefPubMed Collins A, Yuan L, Kiefer TL, Cheng Q, Lai L, Hill SM: Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett. 2003, 189: 49-57. 10.1016/S0304-3835(02)00502-5.CrossRefPubMed
36.
go back to reference Cuenda A, Rousseau S: p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta. 2007, 1773: 1358-1375.CrossRefPubMed Cuenda A, Rousseau S: p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta. 2007, 1773: 1358-1375.CrossRefPubMed
38.
go back to reference Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V: Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene. 2002, 21: 2309-2319. 10.1038/sj.onc.1205297.CrossRefPubMed Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V: Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene. 2002, 21: 2309-2319. 10.1038/sj.onc.1205297.CrossRefPubMed
39.
go back to reference Swarnakar S, Mishra A, Ganguly K, Sharma AV: Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res. 2007, 43: 56-64. 10.1111/j.1600-079X.2007.00443.x.CrossRefPubMed Swarnakar S, Mishra A, Ganguly K, Sharma AV: Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res. 2007, 43: 56-64. 10.1111/j.1600-079X.2007.00443.x.CrossRefPubMed
40.
go back to reference Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Reiter RJ, Swarnakar S: Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res. 2008, 44: 439-449. 10.1111/j.1600-079X.2007.00547.x.CrossRefPubMed Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Reiter RJ, Swarnakar S: Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res. 2008, 44: 439-449. 10.1111/j.1600-079X.2007.00547.x.CrossRefPubMed
41.
go back to reference Woessner JF, Nagase H: Matrix Metalloproteinases and TIMPs (Protein Profile). 2000, New York, NY: Oxford University Press Woessner JF, Nagase H: Matrix Metalloproteinases and TIMPs (Protein Profile). 2000, New York, NY: Oxford University Press
42.
go back to reference Chan AS, Lai FP, Lo RK, Voyno-Yasenetskaya TA, Stanbridge EJ, Wong YH: Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal. 2002, 14: 249-257. 10.1016/S0898-6568(01)00240-6.CrossRefPubMed Chan AS, Lai FP, Lo RK, Voyno-Yasenetskaya TA, Stanbridge EJ, Wong YH: Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal. 2002, 14: 249-257. 10.1016/S0898-6568(01)00240-6.CrossRefPubMed
43.
go back to reference Kilic U, Kilic E, Reiter RJ, Bassetti CL, Hermann DM: Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemic in mice. J Pineal Res. 2005, 38: 67-71. 10.1111/j.1600-079X.2004.00178.x.CrossRefPubMed Kilic U, Kilic E, Reiter RJ, Bassetti CL, Hermann DM: Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemic in mice. J Pineal Res. 2005, 38: 67-71. 10.1111/j.1600-079X.2004.00178.x.CrossRefPubMed
44.
go back to reference Radio NM, Doctor JS, Witt-Enderby PA: Melatonin enhances alkaline phoshoatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res. 2006, 40: 332-342. 10.1111/j.1600-079X.2006.00318.x.CrossRefPubMed Radio NM, Doctor JS, Witt-Enderby PA: Melatonin enhances alkaline phoshoatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res. 2006, 40: 332-342. 10.1111/j.1600-079X.2006.00318.x.CrossRefPubMed
45.
go back to reference Loesch M, Zhi HY, Hou SW, Qi XM, Li RS, Basir Z, Iftner T, Cuenda A, Chen G: p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J Biol Chem. 2010, 285: 15149-15158. 10.1074/jbc.M110.105429.CrossRefPubMedPubMedCentral Loesch M, Zhi HY, Hou SW, Qi XM, Li RS, Basir Z, Iftner T, Cuenda A, Chen G: p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J Biol Chem. 2010, 285: 15149-15158. 10.1074/jbc.M110.105429.CrossRefPubMedPubMedCentral
46.
go back to reference Teplitzky SR, Kiefer TL, Cheng Q, Dwivedi PD, Moroz K, Myers L, Anderson MB, Collins A, Dai J, Yuan L, Spriggs LL, Blask DE, Hill SM: Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett. 2001, 168: 155-163. 10.1016/S0304-3835(01)00548-1.CrossRefPubMed Teplitzky SR, Kiefer TL, Cheng Q, Dwivedi PD, Moroz K, Myers L, Anderson MB, Collins A, Dai J, Yuan L, Spriggs LL, Blask DE, Hill SM: Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett. 2001, 168: 155-163. 10.1016/S0304-3835(01)00548-1.CrossRefPubMed
Metadata
Title
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
Authors
Lulu Mao
Lin Yuan
Lauren M Slakey
Frank E Jones
Matthew E Burow
Steven M Hill
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 6/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2794

Other articles of this Issue 6/2010

Breast Cancer Research 6/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine